Given that even at mild stage of AD, a substantial number of cholinergic synapses may have already degenerated beyond the rescue point, it is not very surprising that the observed increase in soluble ChAT activity was quite mild in the current study following galantamine treatment. This evidence concerns the gene CHAT and Alzheimer disease.